[email protected]
Home > Anticancer Drugs > Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
1 / 5
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir
Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir

Factory 99% Daclatasvir Powder CAS 1009119-64-5 Anti-Cancer Chemical Intermediate Daclatasvir

Still deciding? Get samples of $ !
Request Sample
Send Inquiry

Product Description

i

Basic Information

Model NO.:A701
Name:Daclatasvir
CAS:1009119-64-5
Purity:>99%
Appearance:White Powder
Function:Anti-Cancer
Certification:GMP, HSE, ISO 9001, USP, BP
Suitable for:Elderly, Children, Adult
MOQ:1g
Production Cap.:10000 Kgs Per Month
Origin:China
Package:Foil Bag
P

Product Description

Daclatasvir Banner
Product Name Daclatasvir
Appearance White Powder
CAS NO. 1009119-64-5
MF C40H50N8O6
Storage Keep in a cool, dry, dark location
Daclatasvir Product Image
Daclatasvir is a potent NS5A inhibitor with broad-genotype coverage and high efficacy in combination therapy for the treatment of chronic HCV infection. Its improved tolerability makes it a valuable option for patients seeking to cure their HCV infection.
Treatment Header
  • Treatment of HCV Daclatasvir is primarily used in combination therapy for the treatment of chronic HCV infection. It is often prescribed in conjunction with other antiviral agents to enhance treatment efficacy.
  • Genotype Coverage The drug is effective against multiple HCV genotypes, including genotype 1, which is particularly difficult to treat. This broad-genotype coverage makes daclatasvir a valuable option in a variety of clinical settings.
  • Pan-Genotypic Therapy Daclatasvir can be used in pan-genotypic regimens, simplifying treatment protocols and reducing the need for genotype-specific therapies.
Mechanism Header
  • NS5A Inhibition Daclatasvir functions by inhibiting the NS5A protein of HCV, which is essential for viral replication. By blocking this protein, daclatasvir disrupts the HCV lifecycle and prevents viral spread.
  • Increased Efficacy in Combination Therapy When used in combination with other antiviral agents, daclatasvir enhances the overall efficacy of HCV treatment, leading to higher cure rates and lower relapse rates.
  • Improved Tolerability Daclatasvir is generally well-tolerated, with a low incidence of serious adverse events. This improved tolerability contributes to better patient compliance and adherence to treatment protocols.
Daclatasvir Detail 1
Daclatasvir Detail 2
Daclatasvir Detail 3
Daclatasvir Detail 4
Daclatasvir Detail 5
Daclatasvir Detail 6
?

Frequently Asked Questions

What is Daclatasvir used for?
Daclatasvir is a potent antiviral medication primarily used as an NS5A inhibitor for the treatment of chronic Hepatitis C Virus (HCV) infection, often in combination with other treatments.
What is the purity and appearance of this product?
The product is a high-purity (over 99%) white powder, ensuring its quality for chemical intermediate and research applications.
How should the powder be stored?
To maintain stability and efficacy, it should be kept in a cool, dry, and dark location, away from direct sunlight and moisture.
What is the Minimum Order Quantity (MOQ)?
The minimum order quantity for Daclatasvir powder is 1 gram, making it accessible for both small-scale research and larger production needs.
Which genotypes does Daclatasvir cover?
It offers broad-genotype coverage, including the difficult-to-treat Genotype 1, and can be used in various pan-genotypic treatment regimens.
Is OEM service available?
Yes, OEM services are available to meet specific packaging or specification requirements for your business needs.

Related Products

Shanghai Pemichem Factory Pharmaceutical Chemical 99% Immunosuppressive Drug CAS 104987-11-3 Fujimycin Prozraf/Tacrolimus Powder

Shanghai Pemichem Factory Pharmaceutical Chemical 99% Immunosuppressive Drug CAS 104987-11-3 Fujimycin Prozraf/Tacrolimus Powder
Anti-Cancer CAS 849217-68-1 Cabozantinib Pharmaceutical Cabozantinib

Anti-Cancer CAS 849217-68-1 Cabozantinib Pharmaceutical Cabozantinib
Anti-Cancer CAS 1032900-25-6 Raw Material Ceritinib Powder Ceritinib

Anti-Cancer CAS 1032900-25-6 Raw Material Ceritinib Powder Ceritinib
Factory 99% Ponatinib Powder CAS 943319-70-8 Chemical Intermediate Anti-Cancer Ponatinib

Factory 99% Ponatinib Powder CAS 943319-70-8 Chemical Intermediate Anti-Cancer Ponatinib
Chemical Intermediate Ibrutinib Powder CAS 936563-96-1 Anti-Cancer Ibrutinib

Chemical Intermediate Ibrutinib Powder CAS 936563-96-1 Anti-Cancer Ibrutinib
Anti Cancer API Dasatinib Monohydrate CAS 863127-77-9 Dasatinib Monohydrate

Anti Cancer API Dasatinib Monohydrate CAS 863127-77-9 Dasatinib Monohydrate
Shanghai Pemichem Lab Supply 99% Purity CAS 850140-72-6 Afatinib Raw Material Afatinib Powder Anti-Cancer Afatinib

Shanghai Pemichem Lab Supply 99% Purity CAS 850140-72-6 Afatinib Raw Material Afatinib Powder Anti-Cancer Afatinib
Dasatinib Monohydrate Powder 863127-77-9 Anticancer Dasatinib Monohydrate

Dasatinib Monohydrate Powder 863127-77-9 Anticancer Dasatinib Monohydrate
Dietary Supplement Material Paclitaxel Anticancer Paclitaxel

Dietary Supplement Material Paclitaxel Anticancer Paclitaxel
Antineoplastic Gemcitabine Hydrochloride Anticancer Gemcitabine

Antineoplastic Gemcitabine Hydrochloride Anticancer Gemcitabine